Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Respiratory Research|June 24, 2011
Diagnostic utility of C-reactive protein combined with brain natriuretic peptide in acute pulmonary edema: a cross sectional studyKosaku Komiya, Hiroshi Ishii, Shinji Teramoto, et al.
Oncology Reports|October 25, 2022
Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLCKyoichi Kaira, Hisao Imai, Tomonori Kawasaki, et al.
Discover Oncology|January 20, 2023
Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancerKyoichi Kaira, Ou Yamaguchi, Tomonori Kawasaki, et al.
Clinical Nuclear Medicine|January 10, 2022
Visual Assessment of 18F-FDG Uptake on PET to Predict Survival Benefit to PD-1 Blockade in Non-Small Cell Lung CancerKosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi, et al.
Thoracic Cancer|March 14, 2019
Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancerTakahiro Uchida, Kyoichi Kaira, Ou Yamaguchi, et al.
Frontiers in Oncology|April 1, 2021
Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody TitersAtsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, et al.
Thoracic Cancer|November 13, 2020
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumabOu Yamaguchi, Kyoichi Kaira, Shun Shinomiya, et al.
Oncology Letters|February 2, 2024
Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapyKoki Ito, Kousuke Hashimoto, Kyoichi Kaira, et al.
Thoracic Cancer|February 28, 2019
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patientsAyako Shiono, Kyoichi Kaira, Atsuto Mouri, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 19, 2015
[Hange-Shashin-to for preventing diarrhea during afatinib therapy]Ou Yamaguchi, Akiko Kawashima, Ayako Shiono, et al.
Pageof 10